Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDCorcept Therapeutics Incorporated Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | $0.20 | $0.24 | $0.22 |
| Q2 2024 | 1 | $0.21 | $0.25 | $0.23 |
| Q3 2024 | 1 | $0.28 | $0.29 | $0.28 |
| Q4 2024 | 3 | $0.28 | $0.45 | $0.38 |
| Q1 2025 | 3 | $0.28 | $0.51 | $0.38 |
| Q2 2025 | 2 | $0.38 | $0.45 | $0.41 |
| Q3 2025 | 2 | $0.42 | $0.50 | $0.46 |
| Q4 2025 | 2 | $0.48 | $0.57 | $0.53 |
Corcept Therapeutics Incorporated Earnings Date And Information
Corcept Therapeutics Incorporated last posted its earnings results on Wednesday, October 30th, 2024. The company reported $0.41 earnings per share for the quarter, topping analysts' consensus estimates of $0.28 by $0.13. The company had revenue of 182.55 M for the quarter and had revenue of 482.38 M for the year. Corcept Therapeutics Incorporated has generated $1 earnings per share over the last year ($0.94 diluted earnings per share) and currently has a price-to-earnings ratio of 37.6. Corcept Therapeutics Incorporated has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, February 13th, 2025 based on prior year's report dates.
Corcept Therapeutics Incorporated Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 10/30/2024 | Q3 2024 | $0.28 | $0.45 | 0.17 | $171.97 M | $182.55 M |
| 07/29/2024 | Q2 2024 | $0.23 | $0.34 | 0.11 | $155.14 M | $163.80 M |
| 05/01/2024 | Q1 2024 | $0.22 | $0.27 | 0.05 | $146.81 M | |
| 02/15/2024 | Q4 2023 | $0.26 | $0.30 | 0.04 | $135.41 M | |
| 11/01/2023 | Q3 2023 | $0.22 | $0.31 | 0.09 | $119.71 M | $123.60 M |
| 08/02/2023 | Q2 2023 | $0.15 | $0.27 | 0.12 | $109.60 M | $117.72 M |
| 05/03/2023 | Q1 2023 | $0.19 | $0.15 | -0.04 | $105.65 M | |
| 02/28/2023 | Q4 2022 | $0.23 | $0.15 | -0.08 | $103.06 M | |
| 11/03/2022 | Q3 2022 | $0.23 | $0.30 | 0.07 | $107.57 M | $101.73 M |
| 08/03/2022 | Q2 2022 | $0.24 | $101.00 M | $103.39 M | ||
| 05/05/2022 | Q1 2022 | $0.24 | $0.20 | -0.04 | $93.69 M | |
| 02/15/2022 | Q4 2021 | $0.22 | $0.28 | 0.06 | $98.82 M | |
| 11/03/2021 | Q3 2021 | $0.20 | $0.26 | 0.06 | $97.19 M | $96.13 M |
| 07/29/2021 | Q2 2021 | $0.16 | $0.23 | 0.07 | $86.84 M | $91.59 M |
| 05/06/2021 | Q1 2021 | $0.21 | $0.20 | -0.01 | $79.44 M | |
| 02/23/2021 | Q4 2020 | $0.19 | $0.22 | 0.03 | $85.74 M | |
| 11/03/2020 | Q3 2020 | $0.21 | $0.19 | -0.02 | $90.87 M | $86.33 M |
| 08/04/2020 | Q2 2020 | $0.22 | $0.25 | 0.03 | $90.13 M | $88.57 M |
| 05/04/2020 | Q1 2020 | $0.22 | $0.26 | 0.04 | $93.25 M | |
| 02/24/2020 | Q4 2019 | $0.26 | $87.90 M |
Corcept Therapeutics Incorporated Earnings: FAQ's
When is Corcept Therapeutics Incorporated's earnings date?
Corcept Therapeutics Incorporated has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, February 13th, 2025 based off last year's report dates.
Did Corcept Therapeutics Incorporated beat their earnings estimates last
quarter?
In the previous quarter, Corcept Therapeutics Incorporated (:CORT) reported $0.41 earnings per share (EPS) to beat the analysts' consensus estimate of $0.28 by $0.13.
How can I listen to Corcept Therapeutics Incorporated's earnings conference
call?
The conference call for Corcept Therapeutics Incorporated's latest earnings report can be listened to online.
How can I read Corcept Therapeutics Incorporated's conference call transcript?
The conference call transcript for Corcept Therapeutics Incorporated's latest earnings report can be read online.
How much revenue does Corcept Therapeutics Incorporated generate each year?
Corcept Therapeutics Incorporated (:CORT) has a recorded annual revenue of $482.38 M.
How much profit does Corcept Therapeutics Incorporated generate each year?
Corcept Therapeutics Incorporated (:CORT) has a recorded net income of $482.38 M. Corcept Therapeutics Incorporated has generated $1.02 earnings per share over the last four quarters.
What is Corcept Therapeutics Incorporated's price-to-earnings ratio?
Corcept Therapeutics Incorporated (:CORT) has a price-to-earnings ratio of 37.6 and price/earnings-to-growth ratio is 3.28.